Advertisement
New Zealand markets closed
  • NZX 50

    12,478.50
    -186.50 (-1.47%)
     
  • NZD/USD

    0.6239
    -0.0003 (-0.04%)
     
  • NZD/EUR

    0.5582
    -0.0005 (-0.09%)
     
  • ALL ORDS

    8,437.20
    +20.20 (+0.24%)
     
  • ASX 200

    8,209.50
    +17.60 (+0.21%)
     
  • OIL

    71.77
    -0.18 (-0.25%)
     
  • GOLD

    2,647.10
    +32.50 (+1.24%)
     
  • NASDAQ

    19,791.49
    -48.34 (-0.24%)
     
  • FTSE

    8,229.99
    -98.73 (-1.19%)
     
  • Dow Jones

    42,063.36
    +38.17 (+0.09%)
     
  • DAX

    18,720.01
    -282.37 (-1.49%)
     
  • Hang Seng

    18,258.57
    +245.41 (+1.36%)
     
  • NIKKEI 225

    37,723.91
    +568.58 (+1.53%)
     
  • NZD/JPY

    89.7260
    +0.7580 (+0.85%)
     

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike.

While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics.

Why This 1 Growth Stock Should Be On Your Watchlist

Growth investors build their portfolios around companies that are financially strong and have a bright future, and the Growth Style Score helps take projected and historical earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.

Zoetis (ZTS)

Parsippany, NJ-based Zoetis Inc. came into existence following Pfizer’s decision to spin off its animal health business. The entity started trading on the NYSE on Feb 1, 2013, under the name Zoetis. The company is a leader in the animal health space, which focuses on livestock and companion animals in eight major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, pain and sedation, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species — cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals).

ZTS sits at a Zacks Rank #3 (Hold), holds a Growth Style Score of A, and has a VGM Score of B. Earnings and sales are forecasted to increase 9% and 6.9% year-over-year, respectively.

Five analysts revised their earnings estimate higher in the last 60 days for fiscal 2024, while the Zacks Consensus Estimate has increased $0.04 to $5.80 per share. ZTS also boasts an average earnings surprise of 0.4%.

Zoetis is also cash rich. The company has generated cash flow growth of 10%, and is expected to report cash flow expansion of 6.7% in 2024.

ZTS should be on investors' short lists because of its impressive growth fundamentals, a good Zacks Rank, and strong Growth and VGM Style Scores.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Zoetis Inc. (ZTS) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research